Impact of a statewide childhood vaccine program in controlling hepatitis A virus infections in Alaska

Vaccine

Volumn 28, Issue 38, 2010, Pages 6298-6304

  Singleton, Rosalyn J ^a,b   Hess, Sarah ^a   Bulkow, Lisa R ^b   Castrodale, Louisa ^c   Provo, Ginger ^c   McMahon, Brian J ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b ALASKA NATIVE TRIBAL HEALTH CONSORTIUM   (United States)

^c Alaska Department Health and Social Services   (United States)

Author keywords

Alaska; Alaska Native; Hepatitis A; Hepatitis A vaccine

Indexed keywords

HEPATITIS A VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; CHILD CARE; EPIDEMIC; ESKIMO; HEPATITIS A; HUMAN; INCIDENCE; INFANT; INFECTION PREVENTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RACE DIFFERENCE; UNITED STATES; VACCINATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALASKA; CHILD; CHILD, PRESCHOOL; HEPATITIS A; HUMANS; IMMUNIZATION PROGRAMS; INCIDENCE; INFANT; MIDDLE AGED; POPULATION SURVEILLANCE; YOUNG ADULT;

EID: 77955659814     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.06.113     Document Type: Article

References (30)

1. McMahon B.J., Shapiro C.N., Robertson B.A., Hepatitis A. Bockus gastroenterology 1994, 2044-2061. WB Saunders Company, Philadelphia. 5th ed. W. Haubrich, F. Shaffner, J.E. Berk (Eds.).
2. Centers for Disease Control and Prevention Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1999, 48:1-37.
3. Bell B.P., Shapiro C.N., Alter M.J., Moyer L.A., Judson F.N., Mottram K., et al. The diverse patterns of hepatitis A epidemiology in the United States-implications for vaccination strategies. J Infect Dis 1998, 178(6):1579-1584.
4. Bulkow L.R., Wainwright R.B., McMahonBJ, Middaugh J.P., Jenkerson S.A., Margolis H.S. Secular trends in hepatitis A virus infection among Alaska Natives. J Infect Dis 1993, 168(4):1017-1020.
5. Centers for Disease Control and Prevention Prevention of hepatitis A through active or passive immunization: Recommendations for the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 1996, 45(R-15):6. 22.
6. Innis B.L., Snitbhan R., Kunasol P., Laorakpongse T., Poopatanakool W., Kozik C.A., et al. Protection against hepatitis A by an inactivated vaccine. JAMA 1994, 271(17):1328-1334.
7. Werzberger A., Mensch B., Kuter B., Brown L., Lewis J., Sitrin R., et al. A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children. N Engl J Med 1992, 327(7):453-457.
8. McMahon B.J., Beller M., Williams J., Schloss M., Tanttila H., Bulkow L. A program to control an outbreak of hepatitis A in Alaska by using an inactivated hepatitis A vaccine. Arch Pediatr Adolesc Med 1996, 150(7):733-739.
9. Tulisov A., McMahon B.J., Koch A., Minuk G., Chulanov V., Bruce M.G., et al. Viral hepatitis in the Arctic. A review from a Circumpolar Workshop on Viral Hepatitis. Alaska Med 2007, 49(2 Suppl):193-203.
10. Bialek S.R., Thoroughman D.A., Hu D., Simard E.P., Chattin J., Cheek J., Bell B.P. Hepatitis A incidence and hepatitis A vaccination among American Indians and Alaska Natives, 1990-2001. Am J Public Health 2004, 94(6):996-1001.
11. Centers for Disease Control Prevention Hepatitis A vaccination coverage among children aged 24-35 months-United States, 2006 and 2007. MMWR Morb Mortal Wkly Rep 2009, 58(25):689-694.
12. State of Alaska. Universal Hepatitis A Immunization Program. Department of Health and Social Services, Division of Public Health Section of Epidemiology, Bulletin No. 21, December 14, 1995.
13. State of Alaska. Childhood Vaccination Recommendations Expanded. Division of Public Health Section of Epidemiology, Bulletin No. 40, December 4, 1997.
14. State of Alaska. New School and Childcare Recommendations for Fall, 2001. Department of Health and Social Services, Division of Public Health, Section of Epidemiology, Bulletin No. 21, December 26, 2000.
15. Centers for Disease Control and Prevention. 2007 Nationally Notifiable Infectious Disease: Hepatitis A, Acute [cited August 20, 2008]. Available from: http://www.cdc.gov/ncphi/disss/nndss/casedef/hepatitisacurrent.htm.
16. Centers for Disease Control and Prevention. Summary of National Notifiable Infectious Diseases [cited August 20, 2008]. Available from: http://www.cdc.gov/ncphi/disss/nndss/nndsshis.htm.
17. Centers for Disease Control and Prevention. National Immunization Survey data tables [cited August 25, 2008]. Available from: http://www.cdc.gov/vaccines/stats-surv/imz-coverage.htm%23nis.
18. Centers for Disease Control and Prevention Surveillance for acute viral hepatitis-United States, 2007. MMWR Morb Mortal Wkly Rep 2009, 58(SS03):1-27.
19. Quezada A., Baron-Papillon F., Coudeville L., Maggi L. Universal vaccination of children against hepatitis A in Chile: a cost-effectivenss study. Rev Panam Salud Publica 2008, 23(5):303-312.
20. Averhoff F., Shapiro C.N., Bell B.P., et al. Immunogenicity of an inactivated hepatitis A vaccine in infants and young children. Pediatr Infect Dis J 2007, 26(2):116-122.
21. Peach D., McMahon B.J., Bulkow L., Funk E., Harpaz R., Margolis H.S. Impact of recurrent epidemics of hepatitis A virus infection on population immunity levels: Bristol Bay, Alaska. J Infect Dis 2002, 186(8):1081-1085.
22. Dagan R., Leventhal A., Anis E. Incidence of hepatitis A in Israel following universal immunization of toddlers. JAMA 2005, 294(2):202-210.
23. Dominguez A., Oviedo M., Carmona G., Batalla J., Bruguera M., Salleras L., et al. Impact and effectiveness of a mass hepatitis A vaccination programme of preadolescents seven years after introduction. Vaccine 2008, 26(14):1737-1741.
24. Vacchino M.N. Incidence of hepatitis A in Argentina after vaccination. J Viral Hepat 2008, 15(Suppl 2):47-50.
25. Vitral C.L., Gaspar AMC S.F. Changing epidemiology of hepatitis A in Brazil: reassessing immunization policy. J Viral Hepat 2008, 15(Suppl. 2):22-25.
26. Armstrong G.L., Bell B.P., Hepatitis A virus infections in the United States: model-based estimates and implications for childhood immunization. Pediatrics 2002, 109(5):839-845.
27. Smith P.F., Grabau J.C., Werzberger A., Gunn R.A., Rolka H.R., Kondracki S.F., et al. The role of young children in a community-wide outbreak of hepatitis A. Epidemiol Infect 1997, 118(3):243-252.
28. Lieberman J.M., Word B.M., Jacobs R.J., Dagan R., Marchant C.D. Universal hepatitis A vaccination in the United States: a call for action. Pediatr Infect Dis J 2008, 27(4):287-291.
29. State of Alaska. Hepatitis A, Continuing Rural Spread. Department of Health and Social Services, Division of Public Health, Epidemiology Bulletin No. 16, May 5, 1993. http://www.epi.hss.state.ak.us/bulletins/docs/b1993_16.htm.
30. Castrodale L., Beller M., Middaugh J., McCumber B., Mynes-Spink K., Bernth G. Use of liver function tests to predict the magnitude of an outbreak of hepatitis A. CID 2002, 35(1):91-92.